Weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial.

Trial Profile

Weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2013

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil; Folinic acid; Paclitaxel
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Jul 2013 New trial record
    • 27 Jun 2013 Primary endpoint 'Disease-control-rate' has been met.
    • 27 Jun 2013 Results published in the European Journal of Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top